Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · IEX Real-Time Price · USD
3.76
+0.03 (0.80%)
Aug 8, 2022 4:00 PM EDT - Market closed

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Cash & Equivalents
67.0235.83154.7251.667.88
Short-Term Investments
143.99280.46000
Cash & Cash Equivalents
211.01316.29154.7251.667.88
Cash Growth
-33.29%104.43%199.50%555.75%-
Other Current Assets
4.693.260.990.020.04
Total Current Assets
215.7319.55155.7151.687.91
Property, Plant & Equipment
30.748.790.160.130.1
Other Long-Term Assets
1.241.332.420.010.01
Total Long-Term Assets
31.9810.122.580.140.11
Total Assets
247.68329.67158.351.838.02
Accounts Payable
4.112.541.962.122.07
Other Current Liabilities
19.5411.682.90.450.16
Total Current Liabilities
23.6414.224.862.582.23
Long-Term Debt
28.147.69000
Other Long-Term Liabilities
000.024.020.01
Total Long-Term Liabilities
28.147.690.024.020.01
Total Liabilities
51.7821.914.886.62.24
Total Debt
28.147.69000
Debt Growth
265.74%----
Common Stock
440.13425.373.810.170.11
Retained Earnings
-243.82-118.22-50.97-15.71-6.78
Comprehensive Income
-0.410.61000
Shareholders' Equity
195.9307.76-47.16-15.54-6.68
Total Liabilities and Equity
247.68329.67-42.28-8.94-4.44
Net Cash / Debt
182.87308.6154.7251.667.88
Net Cash / Debt Growth
-40.74%99.45%199.50%555.75%-
Net Cash Per Share
5.059.3874.5425.594.09
Working Capital
192.06305.34150.8549.115.68
Book Value Per Share
5.419.35-22.72-7.70-3.47
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).